Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

5 Must-Read Articles, and an Online Course, to Help Children with ADHD

—–

– Dr. David Rabin­er, Research Pro­fes­sor in the Depart­ment of Psy­chol­o­gy and Neu­ro­science at Duke Uni­ver­sity and founder of the Atten­tion Research Update.

Giv­en the ongo­ing changes and con­tro­ver­sies sur­round­ing ADHD diag­no­sis and treat­ment, let us high­light 5 key arti­cles writ­ten by Duke University’s Dr. David Rabin­er to sum­ma­rize recent sci­en­tif­ic find­ings and their impli­ca­tions, plus a very rel­e­vant online course to help par­ents and pro­fes­sion­als help chil­dren with ADHD.

1. Study finds large gaps between research and prac­tice in ADHD diag­no­sis and treat­ment

  • Key insight: Evi­dence-based guide­lines from the Amer­i­can Acad­e­my of Pedi­atrics on the eval­u­a­tion and treat­ment of ADHD are fre­quent­ly not fol­lowed. Many chil­dren are diag­nosed with ADHD in the absence of clear­ly meet­ing DSM diag­nos­tic cri­te­ria, and behav­ioral treat­ment is rarely rec­om­mend­ed.
  • Key data point: Pedi­a­tri­cians pre­scribed ADHD med­ica­tion to rough­ly 93% of youth diag­nosed with ADHD. Doc­u­men­ta­tion that behav­ioral treat­ment was rec­om­mend­ed, how­ev­er, was present in only 13% of the charts.

Read the rest of this entry »

Growing awareness of the opportunities and risks posed by pharmacological cognitive enhancement (aka “smart drugs”)

Nootropics

.

More research need­ed on use of ‘smart drugs’ by healthy peo­ple (Med­ical News):

Drugs such as methylphenidate and modafinil, mar­ket­ed as Rital­in and Provig­il respec­tive­ly, are used by some healthy indi­vid­u­als in order to boost their cog­ni­tive per­for­mance, despite a gen­er­al lack of knowl­edge about Read the rest of this entry »

Study: Use of methylphenidate-based ADHD medication increases the risk of heart problems

Methylphenidate_pillsADHD med­ica­tion enhances the risk of heart prob­lems in chil­dren (Sci­ence Nordic):

The risk of devel­op­ing heart prob­lems is twice as big for chil­dren tak­ing med­i­cine for Atten­tion Deficit-Hyper­ac­tiv­i­ty Dis­or­der (ADHD) when com­pared to chil­dren not receiv­ing the medicine…The study builds on data from 714,000 chil­dren Read the rest of this entry »

Use and misuse of ADHD drugs and nootropics among teenagers and toddlers

Human-brain-pillsRital­in may pose brain risks for young peo­ple with­out ADHD, study shows (Fox News):

Smart” drugs, like Rital­in, also known as nootrop­ics, are known to increase a person’s atten­tion span, mem­o­ry and abil­i­ty to stay alert. As a result, they have become increas­ing­ly abused by stu­dents seek­ing an extra edge in their stud­ies. Accord­ing to a report from The Part­ner­ship at Drugfree.org and the MetLife Foun­da­tion, approx­i­mate­ly 1.3 mil­lion Amer­i­can teenag­er Read the rest of this entry »

Perspective: Neurofeedback treatment for ADHD is gaining strong support

neurofeedbackNeu­ro­feed­back — also known as EEG Biofeed­back — is an ADHD treat­ment in which indi­vid­u­als learn to alter their typ­i­cal EEG pat­tern to one that is con­sis­tent with a focused, atten­tive state. This is done by col­lect­ing EEG data from indi­vid­u­als as they focus on stim­uli pre­sent­ed on a com­put­er screen. Their abil­i­ty to Read the rest of this entry »

All Slidedecks & Recordings Available — click image below

Search for anything brain-related in our article archives

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters, and more, SharpBrains is an independent market research firm and think tank tracking health and performance applications of brain science.

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.